Viewing Study NCT01022918


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-04-23 @ 5:56 PM
Study NCT ID: NCT01022918
Status: COMPLETED
Last Update Posted: 2012-09-25
First Post: 2009-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
Sponsor: Centre Georges Francois Leclerc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Naive Unresectable Glioblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None unresectable glioblastoma View